Lisa M. Allinson
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Journal: JCO precision oncology
Published: July 16, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Journal: JCO precision oncology
Published: July 01, 2026
Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning.
Journal: Cancer letters
Published: October 07, 2025
Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.
Journal: International journal of molecular sciences
Published: August 12, 2025
Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Journal: Cancers
Published: September 25, 2023
Loss of ALK hotspot mutations in relapsed neuroblastoma.
Journal: Genes, chromosomes & cancer
Published: January 06, 2022
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer.
Journal: Cancers
Published: October 18, 2021
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.
Journal: Molecular cancer therapeutics
Published: October 01, 2019
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia.
Journal: Oncotarget
Published: August 07, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026